Vissum GrupoMiranza advances ocular regenerative medicine with platelet-rich plasma for dry eye disease
Regenerative medicine is revolutionizing the treatment of numerous conditions, including those in ophthalmology. Thanks to increasingly advanced biological therapies, it is now possible to support the body’s natural regenerative processes to help repair damaged tissues in a personalized and minimally invasive way. In this context, platelet-rich plasma (PRP) has become one of the most innovative techniques for regenerating damaged tissues and improving ocular surface health—an area in which Vissum Grupo Miranza is at the forefront.
The Alicante-based clinic continues to invest in these advanced therapies for the treatment of ocular surface diseases, a group of conditions that are becoming increasingly common due to aging, intensive screen use, environmental factors, and certain surgical procedures.
Treatment application
PRP treatment consists of a biological eye drop solution prepared from the patient’s own blood. Following a centrifugation and specialized preparation process, a plasma enriched with growth factors is obtained. These growth factors stimulate cell regeneration and promote the repair of damaged tissues on the ocular surface.
According to Miranza specialists, these growth factors act directly on the cornea and conjunctiva, helping to restore tear film balance, reduce inflammation, and accelerate the body’s natural healing processes. Furthermore, as it is an autologous product (derived from the patient’s own blood), it offers high compatibility and an excellent safety profile.
“The ocular surface must maintain a constant balance to ensure proper lubrication and protection of the eye. When this balance is disrupted, symptoms such as burning, a gritty sensation, irritation, blurred vision, or eye pain can appear. PRP allows us to address not only the symptoms but also the regeneration of damaged tissue”, explain specialists at Vissum Grupo Miranza.
Beyond its lubricating effect, PRP stands out for its anti-inflammatory and regenerative properties. Clinical studies have shown significant improvements in patients with dry eye disease, corneal ulcers, keratitis (inflammation of the cornea), corneal injuries, and ocular surface disorders resulting from the prolonged use of certain eye drops.
The procedure for preparing the treatment is simple and personalized. Through a blood draw similar to a routine laboratory test, the specialized team obtains plasma enriched with growth factors and transforms it into ophthalmic eye drops under strict safety and sterility controls. Patients then apply the drops according to the ophthalmologist’s instructions.